1 | SRRK | Scholar Rock Holding Corporation | 4.51% |
2 | XENE | Xenon Pharmaceuticals Inc. | 4.49% |
3 | KRX: 326030 | SK Biopharmaceuticals Co., Ltd. | 4.43% |
4 | NBIX | Neurocrine Biosciences, Inc. | 4.40% |
5 | BIIB | Biogen Inc. | 4.27% |
6 | DNLI | Denali Therapeutics Inc. | 4.27% |
7 | ACAD | ACADIA Pharmaceuticals Inc. | 4.07% |
8 | SUPN | Supernus Pharmaceuticals, Inc. | 4.06% |
9 | PTCT | PTC Therapeutics, Inc. | 4.04% |
10 | ARGX | argenx SE | 3.97% |
11 | ALKS | Alkermes plc | 3.89% |
12 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.56% |
13 | HLUNB.CO | H. LUNDBECK CLASS B | 3.54% |
14 | BHVN | Biohaven Ltd. | 3.13% |
15 | STO: DYVOX | Dynavox Group AB (publ) | 2.72% |
16 | ASX: NEU | Neuren Pharmaceuticals Limited | 2.44% |
17 | EWTX | Edgewise Therapeutics, Inc. | 2.41% |
18 | AVXL | Anavex Life Sciences Corp. | 2.13% |
19 | IART | Integra LifeSciences Holdings Corporation | 2.12% |
20 | PRAX | Praxis Precision Medicines, Inc. | 2.06% |
21 | TYO: 4592 | SanBio Company Limited | 1.91% |
22 | AVDL | Avadel Pharmaceuticals plc | 1.89% |
23 | SRPT | Sarepta Therapeutics, Inc. | 1.81% |
24 | STO: BIOA.B | BioArctic AB (publ) | 1.80% |
25 | DYN | Dyne Therapeutics, Inc. | 1.79% |
View IBRN holdings |